DeepMed Research

The New York Eye & Ear Infirmary

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Automated AI-based System for Early Diagnosis of Diabetic Retinopathy

Not yet recruiting

Conditions: Diabetic Retinopathy

Interventions: Diagnostic Test: Referable versus Non Referable Diabetic Retinopathy diagnostic test

First Posted Date: 2022-04-12

Last Posted Date: 2022-04-12

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 1000

Registration Number: NCT05324189

Locations: 🇺🇸
New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States

Telemedicine in Age-Related Macular Degeneration

Conditions: Age Related Macular Degeneration

Interventions: Diagnostic Test: Referrable versus Non Referral AMD diagnostic test

First Posted Date: 2021-04-28

Last Posted Date: 2021-04-28

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 1000

Registration Number: NCT04863391

Locations: 🇺🇸
New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States

Age-related Macular Degeneration (AMD) and Cardiovascular Disease

Conditions: Age-related Macular Degeneration
Cardiovascular Diseases
Coronary Artery Disease

Interventions: Genetic: Blood draw

First Posted Date: 2019-09-12

Last Posted Date: 2019-09-12

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 200

Registration Number: NCT04087356

Locations: 🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States

Post Intravitreal Injection Topical NSAID vs. Patching

Phase 4

Conditions: Neovascular Age-related Macular Degeneration
Diabetic Macular Edema
Retinal Vein Occlusion

Interventions: Drug: Theratears tear drop, (Akron, Ann 111 Arbor, MI)
Other: patching
Drug: nepafenac 0.3% suspension (Ilevro; Alcon, Fort Worth, TX)

First Posted Date: 2019-04-17

Last Posted Date: 2019-04-17

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 60

Registration Number: NCT03918590

Locations: 🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States

The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7)

Phase 2

Terminated

Conditions: Glaucoma

Interventions: Procedure: Ologen

First Posted Date: 2016-12-13

Last Posted Date: 2021-03-17

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 30

Registration Number: NCT02990143

Locations: 🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States

Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy

Phase 1

Terminated

Conditions: Open-angle Glaucoma
Diabetic Retinopathy

Interventions: Drug: Placebo
Drug: GlaucoHealth
Drug: GlaucoSelect

First Posted Date: 2016-12-07

Last Posted Date: 2021-03-17

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 21

Registration Number: NCT02984813

Locations: 🇺🇸
New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States

DIM as a Treatment for Thyroid Disease

Early Phase 1

Terminated

Conditions: Proliferative Thyroid Disease

Interventions: Dietary Supplement: Diindolylmethane (DIM)

First Posted Date: 2013-05-03

Last Posted Date: 2013-05-03

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 7

Registration Number: NCT01846364

Locations: 🇺🇸
The New York Eye & Ear Infirmary, New York, New York, United States

Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)

Phase 3

Completed

Conditions: Alopecia

Interventions: Biological: PRFM treatment

First Posted Date: 2012-05-02

Last Posted Date: 2017-02-15

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 15

Registration Number: NCT01590238

Locations: 🇺🇸
The New York Eye & Ear Infirmary, New York, New York, United States

Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

Phase 3

Conditions: Age Related Macular Degeneration

Interventions: Drug: ranibizumab

First Posted Date: 2010-12-07

Last Posted Date: 2011-12-05

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 20

Registration Number: NCT01255774

Locations: 🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States

Outcomes and Patient Experience After Soft Tissue Dermal Filler Injections

Completed

Conditions: Rhytids
Wrinkles

Interventions: Device: hyaluronic acid or calcium hydroxylapatite filler

First Posted Date: 2009-12-18

Last Posted Date: 2012-05-01

Lead Sponsor: The New York Eye & Ear Infirmary

Target Recruit Count: 20

Registration Number: NCT01034956

Locations: 🇺🇸
The New York Eye & Ear Infirmary, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy